ICU Medical, Inc. (ICUI)
NASDAQ: ICUI · Real-Time Price · USD
166.62
-1.71 (-1.02%)
Oct 23, 2026, 4:00 PM EDT - Market closed
ICU Medical Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 2,160 | 2,231 | 2,382 | 2,259 | 2,280 | 1,316 |
Revenue Growth | -8.97% | -6.33% | 5.44% | -0.92% | 73.21% | 3.56% |
Gross Profit Gross Profit Growth | 826.25 | 822.04 | 824.78 | 739.87 | 697.76 | 491.49 |
Operating Income Operating Income Growth | 124.85 | 109.33 | 97.41 | 47.84 | -3.57 | 141.41 |
Net Income Net Income Growth | 30.09 | 0.73 | -117.69 | -29.66 | -74.29 | 103.14 |
Earnings Per Share EPS Growth | 1.20 | 0.03 | -4.83 | -1.23 | -3.11 | 4.74 |
EPS Growth | - | - | - | - | - | 17.91% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Consumables Consumables Growth | 1,137 | 1,109 | 1,039 | 969.13 | 974.99 | 555.19 |
Infusion Systems Infusion Systems Growth | 718.81 | 684.21 | 652.41 | 629.04 | 617.44 | 352.32 |
Vital Care Vital Care Growth | 303.47 | 437.92 | 690.77 | 660.95 | 687.57 | 408.8 |
Revenue (Total) Revenue (Total) Growth | 2,160 | 2,231 | 2,382 | 2,259 | 2,280 | 1,316 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 302.64 | 311.71 | 319.6 | 278.98 | 242.77 | 568.59 |
Total Debt Total Debt Growth | 1,287 | 1,353 | 1,643 | 1,705 | 1,735 | 47.17 |
Net Cash (Debt) Net Cash Growth | -984.52 | -1,041 | -1,323 | -1,426 | -1,492 | 521.42 |
Net Cash Growth | - | - | - | - | - | 45.07% |
Net Cash Per Share Net Cash Per Share Growth | -39.23 | -41.81 | -54.25 | -59.18 | -62.53 | 23.94 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 236.37 | 179.85 | 204.03 | 166.2 | -62.13 | 267.54 |
Capital Expenditures CapEx Growth | -83.54 | -88.04 | -79.37 | -83.89 | -90.31 | -68.54 |
Free Cash Flow Free Cash Flow Growth | 152.83 | 91.8 | 124.66 | 82.31 | -152.44 | 199 |
Free Cash Flow Growth | 152.53% | -26.36% | 51.46% | - | - | 52.20% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 38.26% | 36.84% | 34.63% | 32.75% | 30.60% | 37.34% |
Operating Margin | 5.78% | 4.90% | 4.09% | 2.12% | -0.16% | 10.74% |
Pretax Margin | -0.04% | 0.14% | -2.77% | -3.47% | -5.02% | 9.36% |
Profit Margin | 1.39% | 0.03% | -4.94% | -1.31% | -3.26% | 7.83% |
FCF Margin | 7.08% | 4.11% | 5.23% | 3.64% | -6.69% | 15.12% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 25, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 138.42 | 4811.54 | - | - | - | 48.88 |
Forward PE | 54.10 | 178.72 | 33.92 | 33.92 | 33.92 | 47.09 |
P/FCF Ratio | 27.26 | 38.37 | 30.48 | 29.25 | - | 25.33 |
PS Ratio | 1.93 | 1.58 | 1.60 | 1.07 | 1.66 | 3.83 |